PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $545,000 | +8.1% | 173,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $504,000 | +12.5% | 173,200 | +9.0% | 0.00% | 0.0% |
| Q1 2020 | $448,000 | -30.7% | 158,900 | -20.2% | 0.00% | -33.3% |
| Q4 2019 | $646,000 | -43.1% | 199,100 | -62.1% | 0.00% | 0.0% |
| Q3 2019 | $1,136,000 | +81.2% | 526,000 | +163.1% | 0.00% | 0.0% |
| Q2 2019 | $627,000 | -12.8% | 199,900 | +3.4% | 0.00% | 0.0% |
| Q1 2019 | $719,000 | +17.7% | 193,300 | -8.4% | 0.00% | 0.0% |
| Q4 2018 | $611,000 | -16.6% | 211,000 | -24.3% | 0.00% | 0.0% |
| Q3 2018 | $733,000 | +1.8% | 278,900 | -9.5% | 0.00% | 0.0% |
| Q2 2018 | $720,000 | -0.8% | 308,100 | +24.7% | 0.00% | 0.0% |
| Q1 2018 | $726,000 | +7.4% | 247,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $676,000 | -9.7% | 247,000 | +11.8% | 0.00% | 0.0% |
| Q3 2017 | $749,000 | +11.1% | 221,000 | -19.0% | 0.00% | 0.0% |
| Q2 2017 | $674,000 | -4.8% | 272,900 | -12.6% | 0.00% | 0.0% |
| Q1 2017 | $708,000 | -0.4% | 312,200 | -7.0% | 0.00% | 0.0% |
| Q4 2016 | $711,000 | -3.0% | 335,800 | +53.3% | 0.00% | 0.0% |
| Q3 2016 | $733,000 | -0.4% | 219,000 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $736,000 | +0.4% | 234,400 | +6.4% | 0.00% | 0.0% |
| Q1 2016 | $733,000 | +30.7% | 220,200 | +38.8% | 0.00% | 0.0% |
| Q4 2015 | $561,000 | -29.7% | 158,700 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $798,000 | -15.6% | 158,700 | +8.0% | 0.00% | 0.0% |
| Q2 2015 | $945,000 | -4.4% | 147,000 | +4.5% | 0.00% | 0.0% |
| Q1 2015 | $989,000 | -4.5% | 140,700 | +4.7% | 0.00% | 0.0% |
| Q4 2014 | $1,036,000 | -46.4% | 134,400 | -48.1% | 0.00% | -20.0% |
| Q3 2014 | $1,934,000 | +71.9% | 258,800 | +122.7% | 0.01% | 0.0% |
| Q2 2014 | $1,125,000 | +3.4% | 116,200 | -11.2% | 0.01% | 0.0% |
| Q1 2014 | $1,088,000 | -0.5% | 130,900 | +1.0% | 0.01% | 0.0% |
| Q4 2013 | $1,094,000 | -9.7% | 129,600 | -14.8% | 0.01% | 0.0% |
| Q3 2013 | $1,212,000 | +5.4% | 152,100 | +2.1% | 0.01% | 0.0% |
| Q2 2013 | $1,150,000 | – | 149,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |